378-S: Maternal use of Selective Serotonin Re-Uptake Inhibitors and Risk for Birth Defects
S Alwan(University of British Columbia), Jan M. Friedman(University of British Columbia Hospital), Jennita Reefhuis(Centers for Disease Control and Prevention), Sten Rasmussen(Aalborg University Hospital), Richard S. Olney(University of Iowa)
Cited by 0
Related Papers
A Randomized, Controlled Trial of Total Knee Replacement
|New England Journal of Medicine|2015|817
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Guidelines for case classification for the national birth defects prevention study
|Birth Defects Research Part A Clinical and Molecular Teratology|2003|582
Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review
|American Journal of Epidemiology|2000|535
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
|New England Journal of Medicine|2007|501